FlandersBio offers an up-to-date life sciences database with detailed information about all FlandersBio members.
FlandersBio beschikt over een geüpdate life sciences databank met een gedetailleerd overzicht van alle FlandersBio-ledenbedrijven.
Beta-Cell is a privately owned biopharmaceutical company that develops novel cell therapy and other products related to Diabetes. The company is a spin-off from the Vrije Universiteit Brussel - Diabetes Research Center (VUB-DRC). The DRC is a leader in the biology of insulin-producing beta cells and its use as platform for novel methods in the diagnosis and treatment of diabetes.
The company is a spin-off from the Vrije Universiteit Brussel - Diabetes Research Center (VUB-DRC). The DRC is a leader in the biology of insulin-producing beta cells and its use as platform for novel methods in the diagnosis and treatment of diabetes. It has particular expertise in cell isolation and quality control, stem/precursor cell characterization and differentiation, preparation of standardized beta cell grafts and organization and funding of multi-center clinical trials in diabetes patients. DRC is an internationally recognized center of excellence in the field of diabetes. Beta-Cell’s technology platform is based on prior, current and future work at the DRC. It has acquired proprietary technology for a first product line, with BetaGRAFT® as a lead, and has an agreement on its first right of refusal on all diabetes related Intellectual Property (IP) generated at DRC. Recent developments have opened a second line in the field of beta cell regeneration, with BetaREG as a lead, and a third one in the field of drug screening and discovery, defined as BetaSCREEN.
The company's technology has been transferred from the Diabetes Research Center of the Free University of Brussels, where most methods have been designed. This includes proprietary technology for preparation of diverse cell types from perinatal pig pancreata and for construction of grafts. The company has a unique technology for large-scale production of cell preparations with defined composition and properties. It has a granted patent in Europe and the US entitled "A method for producing preparations of mature and immature pancreatic endocrine cells, the cell preparation and its use for treatment of diabetes mellitus".
Beta-Cell has an exclusive research alliance with the Diabetes Research Center (Vrije Universiteit Brussel), as well as with the university hospital UZBrussel.